Literature DB >> 22402861

Warmer outdoor temperature is associated with worse cognitive status in multiple sclerosis.

Victoria M Leavitt1, James F Sumowski, Nancy Chiaravalloti, John Deluca.   

Abstract

OBJECTIVE: Patients with multiple sclerosis (MS) have more clinical exacerbations and T2 lesion activity during warmer weather. The current study is the first to investigate whether outdoor temperature is related to cognitive status across patients with MS (cross-sectional analysis), and whether cognitive status fluctuates with changes in outdoor temperature within patients with MS (longitudinal analysis).
METHODS: For the cross-sectional analysis, 40 patients with MS and 40 healthy control (HC) subjects were recruited throughout the calendar year. Cognitive status (processing speed, memory) and outdoor temperature were recorded for the day of testing. We calculated partial correlations between cognitive status and temperature for patients with MS and HCs, controlling for demographic and disease variables. For the longitudinal analysis, cognitive status and outdoor temperature were recorded at baseline and 6-month follow-up in a separate sample of 45 patients with MS. We calculated the partial correlation between temperature and cognitive status at follow-up, controlling for baseline temperature and cognitive status (i.e., whether temperature changes are related to cognitive changes within patients with MS).
RESULTS: Cross-sectionally, warmer temperature was related to worse cognitive status in patients with MS (r(p) = -0.45, p = 0.006), not in HCs (r(p) = 0.00, p = 0.984). Longitudinally, increased outdoor temperature from baseline to follow-up was related to a decline in cognitive status within patients with MS (r(p) = -0.39, p = 0.010).
CONCLUSIONS: Cognitive status in patients with MS is worse on warmer days, consistent with a previously established link between heat and lesion activity. Our findings have implications for clinical trial planning, treatment, and lifestyle decisions. We discuss cognitive status as a potential marker of quiescent exacerbations.

Entities:  

Mesh:

Year:  2012        PMID: 22402861      PMCID: PMC3310313          DOI: 10.1212/WNL.0b013e31824d5834

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis.

Authors:  Y Jin; J de Pedro-Cuesta; M Söderström; L Stawiarz; H Link
Journal:  J Neurol Sci       Date:  2000-12-01       Impact factor: 3.181

Review 2.  Thermoregulation in multiple sclerosis.

Authors:  Scott L Davis; Thad E Wilson; Andrea T White; Elliot M Frohman
Journal:  J Appl Physiol (1985)       Date:  2010-07-29

3.  Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.

Authors:  Ralph H B Benedict; Jared M Bruce; Michael G Dwyer; Nadir Abdelrahman; Sarah Hussein; Bianca Weinstock-Guttman; Neeta Garg; Frederick Munschauer; Robert Zivadinov
Journal:  Arch Neurol       Date:  2006-09

4.  Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

Authors:  Ralph H B Benedict; Diane Cookfair; Rebecca Gavett; Mark Gunther; Frederick Munschauer; Neeta Garg; Bianca Weinstock-Guttman
Journal:  J Int Neuropsychol Soc       Date:  2006-07       Impact factor: 2.892

Review 5.  The measurement and clinical relevance of brain atrophy in multiple sclerosis.

Authors:  Robert A Bermel; Rohit Bakshi
Journal:  Lancet Neurol       Date:  2006-02       Impact factor: 44.182

6.  Seasonal prevalence of MS disease activity.

Authors:  D S Meier; K E Balashov; B Healy; H L Weiner; C R G Guttmann
Journal:  Neurology       Date:  2010-08-31       Impact factor: 9.910

7.  The Open-Trial Selective Reminding Test (OT-SRT) as a tool for the assessment of learning and memory.

Authors:  Nancy D Chiaravalloti; Julie Balzano; Nancy B Moore; John DeLuca
Journal:  Clin Neuropsychol       Date:  2009-02       Impact factor: 3.535

8.  Seasonal variation of multiple sclerosis exacerbations in Arizona.

Authors:  C R Bamford; W A Sibley; C Thies
Journal:  Neurology       Date:  1983-06       Impact factor: 9.910

Review 9.  Cognitive impairment in multiple sclerosis.

Authors:  Nancy D Chiaravalloti; John DeLuca
Journal:  Lancet Neurol       Date:  2008-12       Impact factor: 44.182

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  13 in total

1.  Cognitive function and short-term exposure to residential air temperature: A repeated measures study based on spatiotemporal estimates of temperature.

Authors:  Lingzhen Dai; Itai Kloog; Brent A Coull; David Sparrow; Avron Spiro; Pantel S Vokonas; Joel D Schwartz
Journal:  Environ Res       Date:  2016-07-05       Impact factor: 6.498

Review 2.  Injured Brains and Adaptive Networks: The Benefits and Costs of Hyperconnectivity.

Authors:  Frank G Hillary; Jordan H Grafman
Journal:  Trends Cogn Sci       Date:  2017-04-01       Impact factor: 20.229

3.  Age and mitochondrial DNA copy number influence the association between outdoor temperature and cognitive function: Insights from the VA Normative Aging Study.

Authors:  Jacopo Dolcini; Marianthi-Anna Kioumourtzoglou; Akin Cayir; Marco Sanchez-Guerra; Kasey J Brennan; Alexandra E Dereix; Brent A Coull; Avron Spiro; Pantel Vokonas; Joel Schwartz; Andrea A Baccarelli
Journal:  Environ Epidemiol       Date:  2020-08-05

4.  Phantosmia as a meteorological forecaster.

Authors:  S R Aiello; A R Hirsch
Journal:  Int J Biometeorol       Date:  2013-03-01       Impact factor: 3.787

Review 5.  Wearable biosensors to monitor disability in multiple sclerosis.

Authors:  Michael J Bradshaw; Samantha Farrow; Robert W Motl; Tanuja Chitnis
Journal:  Neurol Clin Pract       Date:  2017-08

6.  aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis.

Authors:  Vivien Häußler; Friederike Ufer; Jana Pöttgen; Christine Wolschke; Manuel A Friese; Nicolaus Kröger; Christoph Heesen; Jan-Patrick Stellmann
Journal:  Ann Clin Transl Neurol       Date:  2021-05-05       Impact factor: 4.511

7.  Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial.

Authors:  Dennis Chan; Sophie Binks; Jennifer M Nicholas; Chris Frost; M Jorge Cardoso; Sebastien Ourselin; David Wilkie; Richard Nicholas; Jeremy Chataway
Journal:  Lancet Neurol       Date:  2017-06-07       Impact factor: 44.182

8.  Pathological transitions in myelin membranes driven by environmental and multiple sclerosis conditions.

Authors:  Rona Shaharabani; Maor Ram-On; Yeshayahu Talmon; Roy Beck
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-15       Impact factor: 11.205

9.  Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.

Authors:  Gullvi Flensner; Anne-Marie Landtblom; Olle Söderhamn; Anna-Christina Ek
Journal:  BMC Public Health       Date:  2013-03-15       Impact factor: 3.295

Review 10.  Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain Stimulation.

Authors:  Moussa A Chalah; Naji Riachi; Rechdi Ahdab; Alain Créange; Jean-Pascal Lefaucheur; Samar S Ayache
Journal:  Front Cell Neurosci       Date:  2015-11-30       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.